Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Marketing Part D As Insurance Is Key To Success, PacifiCare Exec Says

Executive Summary

Medicare Part D plan sponsors that can persuade seniors to view the drug benefit as insurance will be the most sucessful, PacifiCare Corporate VP-Public Policy Janet Newport said

You may also be interested in...



Medco Seen As Part D Competitor By UnitedHealth, Analyst Says

Ovations' decision to partner with Walgreens rather than Medco for its Medicare prescription drug plan reflects the expectation that the PBM will become a competitor in the Part D market, Health Strategies Consultancy Medicare Practice Director John Richardson asserted April 19

Medco Seen As Part D Competitor By UnitedHealth, Analyst Says

Ovations' decision to partner with Walgreens rather than Medco for its Medicare prescription drug plan reflects the expectation that the PBM will become a competitor in the Part D market, Health Strategies Consultancy Medicare Practice Director John Richardson asserted April 19

CMS Holds 300 Validated Formularies Prior To Delayed Submission Deadline

The Centers for Medicare & Medicaid Services has received and validated at least 300 drug formularies from potential Part D plan sponsors

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS045749

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel